stay updated with our newsletter

Subscribe
Facebook Twitter Linkedin

The Parasite Cleanse Trend: Exploring Effective Natural Intestinal Parasite Treatments – Part 2

Update 7/15/26: Given the current U.S. Cyclosporiasis outbreak, now is a good time to revisit best practices for diagnosing and treating intestinal parasites. The following article on parasite cleanses summarizes testing strategies, conventional and natural treatment options, and prevention tips that clinicians can use right away.

The parasite cleanse trend promotes that most people need regular antiparasitic treatment because we are all exposed regularly to these lurking creatures. In part 1 of this article series, we defined this trend and covered intestinal parasite diagnostic skills. Now we’ll explore evidence-based natural treatments for intestinal parasites. We’ll also continue to separate hype from fact as you navigate these conversations with patients.

Brief disclosure: I work for a functional medicine laboratory. The views and opinions presented in this article are mine alone and should not be interpreted as representing the official views or policies of Genova Diagnostics or any associated institutions.

Is There Harm in Just Treating Intestinal Parasites Empirically?

The parasite cleanse trend, and belief of some practitioners, is that lab testing for parasites is unreliable, and that it’s best to just treat. Online claims that parasite cleanse consumers feel better after treatment reinforce the idea that testing was never necessary in the first place to have positive outcomes. Herein lies the problem with this approach: many antiparasitic medications and herbal treatments have other mechanisms of action in addition to being antiparasitic. For example, Ivermectin has demonstrated anti-inflammatory effects, and so do many herbal preparations.1-4 Many herbs also have beneficial gut-healing properties. Of course people are going to feel better—but was it really because the treatment killed a parasite?

When treating any condition empirically, clinicians must always weigh the risks of the illness against the risks of treatment. In the case of antiparasitic treatments—whether prescriptive or natural—many have favorable safety profiles, making treatment a less risky option.

So, is there harm in any of this?

One could argue that if a treatment is unlikely to cause harm, its use may be justified—particularly when there is a strong clinical suspicion for a specific parasitic infection.

However, in cases where the clinical picture is vague, the patient’s history does not predispose them to a parasitic infection, and testing is not performed or is negative, patients self-treating with online influencer protocols can be detrimental for many reasons:

  • Treating for potential parasites risks addressing the wrong cause and delaying an accurate diagnosis. Many parasitic symptoms (fatigue, GI distress, skin issues, neurologic complaints) overlap with non-parasitic causes such as other infections, endocrine disorders, or nutritional deficiencies.
  • Lack of targeted therapy. With over 370 parasites5 known to infect humans, each requiring different treatments, how would patients know the appropriate treatment if they never tested?
  • Misleading treatment artifacts and confirmation bias. For example, herbal products like Mimosa pudica may cause patients to pass material that resembles worms but is actually coagulated herb or intestinal mucus.6 This fuels confirmation bias and reinforces the parasite fallacy.
  • Fear-based marketing and chronic dependency. Consumers are led to believe parasites are ubiquitous, creating a perceived need for lifelong, repeated “cleansing.” This fosters false assumptions about health, perpetuates the parasite cleanse trend, and places an ongoing financial burden on patients.
  • Unnecessary exposure to medication risks. Even medications with generally good safety profiles can cause adverse effects (e.g., hepatotoxicity, neurotoxicity, drug–drug interactions).7
  • Microbiome disruption. Many parasite treatment protocols disrupt a healthy microbiome balance. Even herbal protocols can significantly reduce the microbiome population, which I see frequently on stool testing. Regularly “cleansing” or killing commensal organisms can further potentiate a dysbiosis and cause symptoms.
  • Supplement side effects. Some parasite cleansing regimens can be harsh on the gut lining, causing shedding of the protective mucous layer and epithelial cells. The untrained eye may see what appears to be worm-like structures when they are actually destroying the GI tract. Cathartic laxatives should only be used for the short term to avoid adverse events.8

Testing is not perfect (see part 1 of this article), but it is an important tool. Combined with clinical presentation and history taking, testing can help patients receive the correct diagnosis and treatment.

Treating Intestinal Parasites

Many parasitic infections are self-limiting or are easily treatable, unless a patient is immunocompromised and/or malnourished.9 Most people don’t have to routinely “cleanse” parasites unless they live in endemic regions. In developing countries, those with high risk for soil-transmitted helminth infections (hookworm, Ascaris, and whipworm) often receive “preventive chemotherapy,” or antihelminthic treatment without a prior stool examination.10-12 Routine treatments run the risk of promoting drug-resistant strains of parasites and, therefore, should be used only when necessary.13

Pathogenicity of certain parasites is controversial, for example, Blastocystis spp. Some research argues that Blastocystis can be part of a healthy microbiome, and most patients tend to be asymptomatic. In this case, treatment may not be necessary.14,15 However, the CDC does provide treatment options for symptomatic patients, and there are a few clinical studies using natural agents for eradication.

Conventional Treatment of Parasites

The focus of this article is on evidence-based natural treatments. For conventional treatments, check the CDC, Sanford Guide to Antimicrobial Therapy, this article on Antiparasitic Drugs, or other resources for the appropriate, up-to-date treatment for the identified organism.

Be aware that ivermectin, fembendazole, and other antiparasitic medications are now being sold over the counter and online for patients to self-treat. (To learn more about ivermectin and its uses, read “Ivermectin: What’s All the Hype”.)

Depending on the parasite, the conventional treatment may be the more reliable approach. For others, such as Blastocystis spp., metronidazole is the recommended first-line therapy; however, it displays resistance.16,17 I’ve seen this over and again in the lab where clinicians repeat testing, and Blastocystis is still there. There are second-line prescriptive recommendations, and often clinicians will instead opt for natural agents.

Botanicals, Essential Oils, and Other Natural Antiparasitic Agents

Natural products have been used for millennia, and much of the current knowledge is based on a combination of folk medicine uses, a few clinical trials, and clinician experience. Human studies are sparse.

There is not one strictly antiparasitic herb; rather, most herbs treat multiple microorganisms, including bacteria, yeast, and parasites, and have other beneficial biological properties. This is the beauty of herbs, compared to medications, which often have targeted actions. This also may be why herbal antiparasitic blends are likely successful—they are treating underlying general dysbiosis and pathogens and have other healing properties that support gut and overall health.

The general public may not understand that herbs are not targeted antiparasitics, though. Online herbal products with any iteration of the name “Parasite Cleanse” encourage consumers to attribute symptom improvement to parasite eradication, when other explanations are likely. Perhaps these supplements should be accurately described as broad-spectrum dysbiosis or antimicrobial products rather than targeted parasite treatments.

In my experience discussing parasite protocols with hundreds of clinicians over the years, I have found that many use botanical blends offered by various supplement companies and achieve success in treating parasites. Herbal protocols typically last 4-6 weeks. Several herbs and their constituents have antimicrobial activity (including antiparasitic) in vitro and in vivo, including Artemesia annua (sweet wormwood), Juglans nigra (black walnut), Thymus vulgarus (thyme), Origanum vulgare (oregano), Allium sativum (garlic), berberine found in Berberis vulgaris (barberry), Hydrastis canadensis (goldenseal), Berberis aquifolium (Oregon grape), and Coptis chinenesis (goldenthread), and several other herbs and plant constituents.18-23 Supplement companies have various formulations, including these herbs and others. It may be best to contact the supplement companies and ask if they have data on their products in parasite protocols.

A recent systematic review and meta-analysis assessed available studies using traditional medicinal plants in treating intestinal parasites in humans. The authors concluded that more research was needed, and ultimately, no treatment recommendations were made. Most studies were in vivo and in vitro. In vivo/in vitro doesn’t always translate to human efficacy. They found that overall, 91 plant species and 34 plant compounds had significant antiparasitic activity in vitro. Plant species in the Artemesia genus were tested against the most diverse range of parasites, including Blastocystisspp., Giardia duodenalis, Entamoeba histolytica, Ascaris lumbricoides, and Taenia solium. A total of 38 plant species and 6 plant compounds had significant antiparasitic activity in vivo. Only 3 randomized controlled trials were evaluated, showing significant efficacy with Saussurea lappa and Nigella sativa (black cumin) against certain nematodes and cestodes, respectively. Butea monosperma and Piper longum were effective against Giardia.24

A small study examined the effect of oil of oregano on 14 patients with positive O&P stool testing for enteric parasites. They were supplemented with 200 mg oregano oil (A.D.P. from Biotics Research) three times daily with meals for 6 weeks. Protozoal parasites detected included Blastocystis spp., and non-pathogenic parasites Entamoeba hartmanni, and Endolimax nana. Out of 13 patients completing the protocol, parasites could no longer be detected in 10 patients (77%). All 13 individuals experienced a decrease in symptoms, including bloating, GI cramping, alternating diarrhea and constipation, and fatigue.25

A clinical trial on 20 patients infected with Entamoeba histolytica studied the effects of Artemisia absinthum (wormwood) at a dose of 500 mg three times daily for 15 days. Following treatment, evidence of E. histolytica in stool testing resolved in 70% of cases. There was significant symptom improvement, and the treatment was well tolerated.26Thujone is the primary antimicrobial constituent in Artemisia and has neurotoxic potential.

In an older study, 137 children with Giardia were given either berberine (5 mg/kg/day or 10 mg/kg/day) or metronidazole for 10 days. 90% of the 10 mg/kg/day berberine group no longer had Giardia in their stools, compared to 95% of the metronidazole group. Berberine was not associated with any side effects.27

Mimosa pudica is a popular online supplement promoted as an antiparasitic agent. It has in vitro activity against certain bacteria, yeast, and helminths.28-31 It showed weak antihelminthic activity, and antimalarial activity in mice.32,33 While this is promising, there are no human studies.

Mimosa pudica has antibiofilm activity and is capable of removing muco-biofilm structures.34,35 This may be why, if you read online reports from supplement buyers, there are reports of passage of “worms” in the stool after taking this product—when it may just be a sloughing of mucus and biofilm in their gut. Or it may be the supplement itself causing a clumping effect in the gut. This is described in case reports of patients taking the supplement, yet testing negative in all parasitology workups.6 The issue is not that this herb lacks potential benefit; many clinicians anecdotally report positive effects. Rather, the concern is that direct-to-consumer companies are misleading consumers by implying parasitic infection without adequate evidence.

Lactoferrin is an iron-binding protein naturally present in colostrum and breastmilk and supports the immune response in newborns. The number and intensity of infections with Cryptosporidium, Entamoeba histolytica, Giardia, and Blastocystis were significantly lower in breast-fed infants than in non-breast-fed infants.36 Lactoferrin is also present in tears, saliva, and on mucosal surfaces in the respiratory, reproductive, and GI tracts. Lactoferrin and colostrum are often prescribed as gut health supplements; however, clinical studies are needed to confirm efficacy against intestinal parasites.37

What About Biofilm Disruptors?

A biofilm is defined as “a microbial community irreversibly associated with a surface and enclosed in an extracellular polymeric substance matrix.” Biofilms are generally described in the context of forming on surfaces such as water distribution pipes, which can carry parasitic and other microbial diseases.38 Biofilms can also form inside the human body and are most commonly associated with medical implants.39 Biofilms can be present in a healthy or unhealthy gut, and there is concern that they may provide a hiding place for parasites, making them more difficult to treat, and contributing to antibiotic resistance. Some protozoal species, including Entamoeba histolytica, are known to feed on biofilms, naturally damaging the biofilm matrix.40,41

Biofilm disruptors are gaining popularity in functional medicine treatments, and they do have their place. Biofilm is not only going to capture possible parasites, but also other bugs like yeast and bacteria.42 So in the process of biofilm disruption, a person may feel better because they are unloading a buildup of other organisms—it cannot only be attributed to parasites.

However, there is a delicate balance in disrupting the biofilm, as some biofilms are produced by beneficial probiotic bacteria. These biofilms benefit the host by preventing colonization of pathogens, promoting the colonization of beneficial bacteria, and enhancing host defense.40

Probiotics to Treat Parasites?

Probiotic supplements may be a helpful therapy against parasites and in rebalancing the microbiome. Probiotics may displace or outcompete pathogens, produce antimicrobial products, enhance gut barrier function, and alter the immune response.43-45 In vitro, animal, and a few case studies show the efficacy of several Lactobacillus and Bifidobacteriumspecies against Blastocystis, Cryptosporidium parvum, Giardia lamblia, worms, and other intestinal and extra-intestinal parasites.44,46

Saccharomyces boulardii, a probiotic yeast, was studied in a randomized single-blinded clinical trial in 48 children with O&P confirmed Blastocystis spp. infection. For 10 days, group A received 250 mg S. boulardii twice daily, group B received metronidazole (30 mg/kg) twice daily, and group C, no treatment. On day 15, clinical cure (resolution of symptoms) was achieved in 77.7% of group A, 66.6% group B, and 40% group C. Negative stool tests were 72.2% in group A, 80% in group B, and 26.6% in group C.47

A few important points can be gleaned from this study. It’s compelling that a probiotic has similar efficacy as an antibiotic. Although metronidazole is the recommended first-line treatment, it does display varying degrees of resistance.17 We also learn that the infection can be self-limiting in a percentage of the population (group C). Also, the presence of Blastocystisdoesn’t always correlate with symptoms.

A similar study evaluated S. boulardii for Giardia lamblia in 65 adults. Patients were given metronidazole plus twice daily 250 mg S. boulardii or metronidazole plus placebo for 10 days. At the end of 2 and 4 weeks, Giardia persisted in 17.1% of the placebo group, versus none in the S. boulardii group. These findings suggest that S. bouldardii can be used as an effective adjunctive therapy in treating Giardia.48 Similarly, in 54 adults and 50 children with Entamoeba histolytica, adding S. boulardii (250 mg three times daily for 10 days) to standard therapy improved eradication rates and shortened symptom duration.49,50

Biotoxin Binders and Herxheimer Reactions

Many online parasite cleanse protocols include a binder containing substances such as humic and fulvic acids, zeolite, activated charcoal, bentonite clay, and others. These substances adsorb to toxins, including toxic metals that are thought to be released from some helminths during treatment. There are no clinical studies using these substances in parasite treatment.8,51 Studies on helminths known to infect animals and not humans show heavy metal bioconcentration.52,53 It is likely that helminths that infect humans also bioaccumulate metals.

A Herxheimer reaction is a cytokine-mediated inflammatory response occurring following antibiotic treatment for spirochete infections. Symptoms can include headache, fever, myalgia, nausea, vomiting, malaise, and flushing.54 Many attribute symptoms patients experience during parasite treatment to the organism “die-off”, which may or may not be a true Herxheimer reaction. Regardless, the symptoms can be troublesome for the patient. It is believed that a binder can minimize the die-off reaction by binding to parasites or their metabolic products released during eradication. There is no literature showing that binders prevent a Herxheimer reaction.54-56

Since most intestinal parasite cleanse protocols have broad-spectrum antimicrobial activity, die-off of other organisms, such as spirochetes, bacteria, and yeast are more likely to cause symptoms associated with the Herxheimer reaction.54,57 In fact, those with tick-borne illnesses are more likely to experience this reaction. However, most tick-borne illnesses are not parasitic infections; they are often caused by spirochetes or other bacteria, but some are caused by protozoa.54,58 The burden of tick-borne illness is highly underdiagnosed, and a comprehensive functional medicine approach can sometimes unmask the issue.59 Still, having the appropriate diagnosis is important—is it a tick-borne illness or a parasitic infection? Each diagnosis requires a different approach, therefore testing is important.

Endotoxins released from bacteria and yeast, and glycoconjugates on the surface of protozoan parasites can promote an immunological effect.57,60,61 Many clinicians use binders for offsetting these symptoms, however there are no clinical studies demonstrating this. These binders can also bind and strip the body of nutrients, minerals, and electrolytes, so it is important to use them short-term and replace nutrients.8

Serum-derived bovine immunoglobulin (SBI) protein isolate has been shown to bind to a wide array of bacterial, viral, and fungal pathogen-associated molecular patterns (PAMPs), preventing them from damaging the gut lining and triggering inflammation.62,63 This biological binder may be a good adjunct to consider in antimicrobial protocols, although there is no literature suggesting benefit with intestinal protozoal or helminth infections.

Antiparasitic Foods

Several foods are included in traditional diets for their antiparasitic potential. In vitro and in vivo studies show anthelmintic activity of pumpkin (Curcubita pepo) seeds and garlic.64-67 Human studies are sparse. Anecdotally, Umeboshi plums are a popular treatment in the Naturopathic community, however there are no clinical studies.

A study on 60 asymptomatic Nigerian children with stool microscopic evidence of 7 species of intestinal parasites (both helminths and protozoa) examined the effects of papaya seeds. Children were given one dose of either an elixir of papaya seeds with honey or honey alone. The participants receiving the elixir were given a dose of 20 mL, equivalent to 4 grams of dried papaya seeds. Seven days later, repeat microscopic exams showed 76.7% clearance of parasites in the papaya seed group versus only 16.7% in the honey-only group. Papaya is a readily available fruit in tropical regions where parasite infections are prevalent.68

A Comprehensive Functional Medicine Treatment Approach

A 5-R (Remove, Replace, Reinoculate, Repair, Rebalance) approach that improves overall GI function can strengthen the defense against parasites and other pathogenic organisms. As discussed in part 1, post-infectious irritable bowel syndrome (IBS) is best addressed with a gut healing protocol that focuses on gut lining repair and microbiome balancing.69,70 Supporting immunocompetence is also helpful. Adjunctive nutrients that support immune function and resistance to parasitic infection include vitamin A, selenium, and zinc.71

Preventing Parasite Infections

Effective parasite prevention requires coordinated action at both the regulatory and individual levels, combining public health measures that reduce population-wide exposure with personal practices that limit everyday risk and reinfection. Intestinal parasites are spread via soil, food, water, and surfaces that are contaminated with feces from infected humans or animals. The CDC has an educational page for patients to read. The following factors are important to consider when taking a patient history and for preventing intestinal parasite infections and reinfection:12,13,72-75

  • Travel to and immigration from countries that have endemic parasites (travel with herbs or other preventive medications to minimize contracting illness)
  • Cultural hygiene practices and living conditions (crowded conditions, home sanitation, hand-washing after using the toilet, etc.)
  • Community sanitation programs (drinking water and waste disposal)
  • Outbreaks (mainly through food; CDC has updates)
  • Daycare settings (children and daycare workers)
  • Outdoor lifestyles and backcountry camping
  • Lowered immunity
  • Exposure to household pets who spend a lot of time outdoors, farm animals, wild animals (staying up-to-date on domesticated animal deworming prevents transmission)
  • Use of untreated, non-potable water
  • Exposure to manure/fertilizers
  • Consumption of unwashed, uncooked fruits and vegetables
  • Consumption of undercooked meat or seafood like sushi, ceviche, rare or raw meats, etc. (cooking thoroughly and/or freezing first reduces risk)
  • Walking barefoot in areas where animals or humans defecate
  • Exposure to human feces through sexual contact (barriers can avoid spread)
  • Age (infants and elderly more at risk)
  • Low stomach acid

Considering this list, the parasite cleanse trend is very convincing that “everyone has parasites” and therefore must be treated regularly. It’s important to remember that exposure does not necessarily mean infection. This is why testing is important (see part 1).

It may seem elementary, but encouraging basic hygiene measures such as hand washing goes a long way. Hand washing is one of the most important interventions proven to decrease fecal-oral transmission of disease.13 Enterobius vermicularis (pinworm) is the most common intestinal helminth infection in the United States and is usually found in children.76 It causes an itchy rectum, which can lead to eggs in fingernails, which can be easily spread. Finger sucking in young children is highly correlated with this infection.13 Teaching children the importance of hand washing can help prevent infection.

While one can practice an utmost hygiene regimen, there will always be factors beyond our control. For example, we cannot control whether the restaurant worker preparing your food washed their hands. This is why a holistic treatment approach and immune support are as important as practicing the behaviors that prevent parasitic disease spread.

Final Thoughts on the Parasite Cleanse Trend

Routine, universal parasite cleansing is not a best practice unless the patient lives in or regularly travels to an endemic area. When parasites are suspected, a thorough clinical history is essential, and a definitive diagnosis should be confirmed through appropriate testing. A comprehensive stool analysis that includes multiple types of parasite testing is preferred to ensure adequate coverage (see part 1 for testing options). These analyses also assess additional functional biomarkers that can support differential diagnosis and help explain a patient’s symptoms.

Symptom improvement after an online herbal parasite cleanse does not necessarily indicate that parasites were expelled or eradicated, unless testing was indeed positive. While parasites can be a root cause of several conditions, clinicians should continue to investigate and address all other potential underlying contributors to symptoms.

Helpful Resources

References:

  1. Ci X, Li H, Yu Q, et al. Avermectin exerts anti-inflammatory effect by downregulating the nuclear transcription factor kappa-B and mitogen-activated protein kinase activation pathway. Fundamental & clinical pharmacology. 2009;23(4):449-455.
  2. Stein L, Kircik L, Fowler J, et al. Efficacy and safety of ivermectin 1% cream in treatment of papulopustular rosacea: results of two randomized, double-blind, vehicle-controlled pivotal studies. Journal of drugs in dermatology : JDD. 2014;13(3):316-323.
  3. Rodrigues D, Porto JCS, Dos Santos IL, Filho J, Ferreira PMP. Repositioning anthelmintics for the treatment of inflammatory-based pathological conditions. Inflammopharmacology. 2025;33(2):551-571.
  4. Khan MUA, Akhtar T, Naseem N, Aftab U, Hussain S, Shahzad M. Evaluation of therapeutic potential of ivermectin against complete Freund’s adjuvant-induced arthritis in rats: Involvement of inflammatory mediators. Fundamental & clinical pharmacology. 2023;37(5):971-982.
  5. Cox FE. History of human parasitology. Clinical microbiology reviews. 2002;15(4):595-612.
  6. Tabbalat RR, Cal NV, Mayigegowda KK, Desilets DJ. Two Cases of Gastrointestinal Delusional Parasitosis Presenting as Folie á Deux. ACG case reports journal. 2019;6(8):e00183.
  7. Campbell S, Soman-Faulkner K. Antiparasitic Drugs. In: StatPearls. Treasure Island (FL): 2025, StatPearls Publishing LLC.; 2025.
  8. Paul C, Brady DM. Pseudoscientific and Unhealthy Approaches to Gastrointestinal Health and Detoxification in Natural Medicine. Integrative medicine (Encinitas, Calif). 2023;22(1):26-29.
  9. Khubchandani IT, Bub DS. Parasitic Infections. Clinics in colon and rectal surgery. 2019;32(5):364-371.
  10. Hotez PJ, Brooker S, Bethony JM, Bottazzi ME, Loukas A, Xiao S. Hookworm infection. The New England journal of medicine. 2004;351(8):799-807.
  11. Marocco C, Bangert M, Joseph SA, Fitzpatrick C, Montresor A. Preventive chemotherapy in one year reduces by over 80% the number of individuals with soil-transmitted helminthiases causing morbidity: results from meta-analysis. Transactions of the Royal Society of Tropical Medicine and Hygiene. 2017;111(1):12-17.
  12. CDC. About Soil-transmitted helminths. Soil-Transmitted Helminths 2024; https://www.cdc.gov/sth/about/?CDC_AAref_Val=https://www.cdc.gov/parasites/sth/index.html, Accessed 2025.
  13. Alum A, Rubino JR, Ijaz MK. The global war against intestinal parasites–should we use a holistic approach? International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases. 2010;14(9):e732-738.
  14. Coyle CM, Varughese J, Weiss LM, Tanowitz HB. Blastocystis: to treat or not to treat. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2012;54(1):105-110.
  15. Sekar U, Shanthi M. Blastocystis: Consensus of treatment and controversies. Tropical parasitology. 2013;3(1):35-39.
  16. Ulusan Bağcı Ö, Aral Akarsu G. A Systematic Review about the Efficacy of Antiparasitic Agents in the Treatment of Blastocystis Species. Acta parasitologica. 2025;70(6):208.
  17. Pawelec-Pęciak O, Łanocha-Arendarczyk N, Grzeszczak K, Kosik-Bogacka D. The Role of Blastocystis spp. in the Etiology of Gastrointestinal and Autoimmune Diseases. Pathogens (Basel, Switzerland). 2025;14(4).
  18. Strothmann AL, Berne MEA, Capella GA, et al. Antiparasitic treatment using herbs and spices: A review of the literature of the phytotherapy. Brazilian journal of veterinary medicine. 2022;44:e004722.
  19. Septembre-Malaterre A, Lalarizo Rakoto M, Marodon C, et al. Artemisia annua, a Traditional Plant Brought to Light. International journal of molecular sciences. 2020;21(14).
  20. Ranasinghe S, Armson A, Lymbery AJ, Zahedi A, Ash A. Medicinal plants as a source of antiparasitics: an overview of experimental studies. Pathogens and global health. 2023;117(6):535-553.
  21. Khalil RG, Ibrahim AM, Bakery HH. Juglone: “A novel immunomodulatory, antifibrotic, and schistosomicidal agent to ameliorate liver damage in murine schistosomiasis mansoni”. International immunopharmacology. 2022;113(Pt A):109415.
  22. Gaur S, Kuhlenschmidt TB, Kuhlenschmidt MS, Andrade JE. Effect of oregano essential oil and carvacrol on Cryptosporidium parvum infectivity in HCT-8 cells. Parasitology international. 2018;67(2):170-175.
  23. Berberine. Alternative medicine review : a journal of clinical therapeutic. 2000;5(2):175-177.
  24. Ranasinghe S, Aspinall S, Beynon A, Ash A, Lymbery A. Traditional medicinal plants in the treatment of gastrointestinal parasites in humans: A systematic review and meta-analysis of clinical and experimental evidence. Phytotherapy research : PTR. 2023;37(9):3675-3687.
  25. Force M, Sparks WS, Ronzio RA. Inhibition of enteric parasites by emulsified oil of oregano in vivo. Phytotherapy research : PTR. 2000;14(3):213-214.
  26. Tahir M, Siddiqui M, Khan A. Effect of afsanteen (Artemisia absinthium Linn.) in acute intestinal amoebiasis. 1997.
  27. Gupte S. Use of berberine in treatment of giardiasis. American journal of diseases of children (1960). 1975;129(7):866.
  28. Ahmad H, Sehgal S, Mishra A, Gupta R. Mimosa pudica L. (Laajvanti): An overview. Pharmacognosy reviews. 2012;6(12):115-124.
  29. Harshita S, Spandana A, Shilpa R, Abhishek K. Phytochemistry, Pharmacological Activities, and Ethnomedical Significance of Mimosa pudica L. Journal of Pharma Insights and Research. 2025;3(5):252-259.
  30. Bendgude R, Maniyar M, Kondawar M, Patil S, Hirave R. Anthelmintic activity of leaves of Mimosa pudica. Int J Inst Pharm Life Sci. 2012;2(1):120-125.
  31. Adurosakin OE, Iweala EJ, Otike JO, et al. Ethnomedicinal uses, phytochemistry, pharmacological activities and toxicological effects of Mimosa pudica-A review. Pharmacological Research-Modern Chinese Medicine. 2023;7:100241.
  32. Nzeakor TA, Udobi MI, Eke IG, et al. Evidence-based investigations into the ethnoveterinary use of Mimosa pudica L.(Fabaceae) as an anthlemintic. Tropical Journal of Pharmaceutical Research. 2020;19(12):2623-2630.
  33. Aarthi N, Murugan K. Antimalarial activity and phytochemical screening of ethanolic leaf extract of Phyllanthus niruri and Mimosa pudica. Int J Pharm Res Dev. 2011;3(3):198-205.
  34. Pinheiro E. Pharmacological Potentials of Mimosa pudica: Antiparasitic, Antibiofilm and Mucolytic Activities. Pharmaceutical Science: New Insights and Developments.114.
  35. Elizabeth P. Antiparasitic, Antibiofilm, and Mucolytic Activities of Mimosa pudica: An Integrative Literature Review. European Journal of Medicinal Plants. 2025;36(4):174-182.
  36. Abdel-Hafeez EH, Belal US, Abdellatif MZ, Naoi K, Norose K. Breast-feeding protects infantile diarrhea caused by intestinal protozoan infections. The Korean journal of parasitology. 2013;51(5):519-524.
  37. León-Sicairos N, Ordaz-Pichardo C, Carrero JC, de la Garza M. Lactoferrin in the Battle against Intestinal Parasites: A Review. In: Natural Remedies in the Fight Against Parasites. InTech; 2017.
  38. Lefebvre M, Razakandrainibe R, Villena I, Favennec L, Costa D. Cryptosporidium-Biofilm Interactions: a Review. Applied and environmental microbiology. 2021;87(3).
  39. Shahrour H, Ferrer-Espada R, Dandache I, et al. AMPs as Anti-biofilm Agents for Human Therapy and Prophylaxis. Advances in experimental medicine and biology. 2019;1117:257-279.
  40. Zanditenas E, Trebicz-Geffen M, Kolli D, et al. Digestive exophagy of biofilms by intestinal amoeba and its impact on stress tolerance and cytotoxicity. NPJ biofilms and microbiomes. 2023;9(1):77.
  41. Zanditenas E, Ankri S. Unraveling the interplay between unicellular parasites and bacterial biofilms: Implications for disease persistence and antibiotic resistance. Virulence. 2024;15(1):2289775.
  42. Menezes RP, Bessa MAS, Siqueira CP, et al. Antimicrobial, Antivirulence, and Antiparasitic Potential of Capsicum chinense Jacq. Extracts and Their Isolated Compound Capsaicin. Antibiotics (Basel, Switzerland). 2022;11(9).
  43. Milner E, Stevens B, An M, et al. Utilizing Probiotics for the Prevention and Treatment of Gastrointestinal Diseases. Frontiers in microbiology. 2021;12:689958.
  44. Travers MA, Florent I, Kohl L, Grellier P. Probiotics for the control of parasites: an overview. Journal of parasitology research. 2011;2011:610769.
  45. Mandal S, Mondal C, Lyndem LM. Probiotics: an alternative anti-parasite therapy. Journal of parasitic diseases : official organ of the Indian Society for Parasitology. 2024;48(3):409-423.
  46. Lepczyńska M, Dzika E. The influence of probiotic bacteria and human gut microorganisms causing opportunistic infections on Blastocystis ST3. Gut pathogens. 2019;11:6.
  47. Dinleyici EC, Eren M, Dogan N, Reyhanioglu S, Yargic ZA, Vandenplas Y. Clinical efficacy of Saccharomyces boulardii or metronidazole in symptomatic children with Blastocystis hominis infection. Parasitology research. 2011;108(3):541-545.
  48. Besirbellioglu BA, Ulcay A, Can M, et al. Saccharomyces boulardii and infection due to Giardia lamblia. Scandinavian journal of infectious diseases. 2006;38(6-7):479-481.
  49. Mansour-Ghanaei F, Dehbashi N, Yazdanparast K, Shafaghi A. Efficacy of saccharomyces boulardii with antibiotics in acute amoebiasis. World journal of gastroenterology : WJG. 2003;9(8):1832-1833.
  50. Dinleyici EC, Eren M, Yargic ZA, Dogan N, Vandenplas Y. Clinical efficacy of Saccharomyces boulardii and metronidazole compared to metronidazole alone in children with acute bloody diarrhea caused by amebiasis: a prospective, randomized, open label study. Am J Trop Med Hyg. 2009;80(6):953-955.
  51. Zellner T, Prasa D, Färber E, Hoffmann-Walbeck P, Genser D, Eyer F. The Use of Activated Charcoal to Treat Intoxications. Deutsches Arzteblatt international. 2019;116(18):311-317.
  52. Sures B, Nachev M, Selbach C, Marcogliese DJ. Parasite responses to pollution: what we know and where we go in ‘Environmental Parasitology’. Parasites & vectors. 2017;10(1):65.
  53. Brázová T, Hanzelová V, Miklisová D, Šalamún P, Vidal-Martínez VM. Host-parasite relationships as determinants of heavy metal concentrations in perch (Perca fluviatilis) and its intestinal parasite infection. Ecotoxicology and environmental safety. 2015;122:551-556.
  54. Wood JM, Sbar E. Jarisch-Herxheimer Reaction. In: StatPearls. Treasure Island (FL):Copyright © 2025, StatPearls Publishing LLC.; 2025.
  55. Young EJ, Weingarten NM, Baughn RE, Duncan WC. Studies on the pathogenesis of the Jarisch-Herxheimer reaction: development of an animal model and evidence against a role for classical endotoxin. The Journal of infectious diseases. 1982;146(5):606-615.
  56. Butler T. The Jarisch-Herxheimer Reaction After Antibiotic Treatment of Spirochetal Infections: A Review of Recent Cases and Our Understanding of Pathogenesis. Am J Trop Med Hyg. 2017;96(1):46-52.
  57. Jaiswal N, Kumar A. Candida die-off: Adverse effect and neutralization with phytotherapy approaches. Toxicon : official journal of the International Society on Toxinology. 2024;237:107555.
  58. Yune PS, Islam I, Dicpinigaitis PV, Daily JP, Weiss LM, Park SO. A Case Report and Literature Review of Babesiosis-Induced Acute Respiratory Distress Syndrome. Case reports in infectious diseases. 2022;2022:4318731.
  59. Rodino KG, Theel ES, Pritt BS. Update on North American tick-borne diseases and how to diagnose them. J Clin Microbiol. 2025;63(8):e0080723.
  60. Guha-Niyogi A, Sullivan DR, Turco SJ. Glycoconjugate structures of parasitic protozoa. Glycobiology. 2001;11(4):45r-59r.
  61. Jiménez JC, Morelle W, Michalsky JC, Dei-Cas E. Excreted/secreted glycoproteins of G. intestinalis play an essential role in the antibody response. Parasitology research. 2007;100(4):715-720.
  62. Horgan A, Maas K, Henderson A, Detzel C, Weaver E. Serum‐derived bovine immunoglobulin/protein isolate binds to pathogen‐associated molecular patterns (836.6). The FASEB Journal. 2014;28:836.836.
  63. Petschow BW, Burnett B, Shaw AL, Weaver EM, Klein GL. Serum-derived bovine immunoglobulin/protein isolate: postulated mechanism of action for management of enteropathy. Clinical and experimental gastroenterology. 2014;7:181-190.
  64. Grzybek M, Kukula-Koch W, Strachecka A, et al. Evaluation of Anthelmintic Activity and Composition of Pumpkin (Cucurbita pepo L.) Seed Extracts-In Vitro and in Vivo Studies. International journal of molecular sciences. 2016;17(9).
  65. Soffar SA, Mokhtar GM. Evaluation of the antiparasitic effect of aqueous garlic (Allium sativum) extract in hymenolepiasis nana and giardiasis. Journal of the Egyptian Society of Parasitology. 1991;21(2):497-502.
  66. Bayan L, Koulivand PH, Gorji A. Garlic: a review of potential therapeutic effects. Avicenna journal of phytomedicine. 2014;4(1):1-14.
  67. El-Shewehy DMM, Elshopakey GE, Ismail A, Hassan SS, Ramez AM. Therapeutic Potency of Ginger, Garlic, and Pomegranate Extracts Against Cryptosporidium parvum-Mediated Gastro-Splenic Damage in Mice. Acta parasitologica. 2023;68(1):32-41.
  68. Okeniyi JA, Ogunlesi TA, Oyelami OA, Adeyemi LA. Effectiveness of dried Carica papaya seeds against human intestinal parasitosis: a pilot study. Journal of medicinal food. 2007;10(1):194-196.
  69. Blitz J, Riddle MS, Porter CK. The Risk of Chronic Gastrointestinal Disorders Following Acute Infection with Intestinal Parasites. Frontiers in microbiology. 2018;9:17.
  70. Berumen A, Edwinson AL, Grover M. Post-infection Irritable Bowel Syndrome. Gastroenterology clinics of North America. 2021;50(2):445-461.
  71. Shea-Donohue T, Qin B, Smith A. Parasites, nutrition, immune responses and biology of metabolic tissues. Parasite immunology. 2017;39(5).
  72. CDC. What Causes Parasitic Diseeases. Parasites 2024; https://www.cdc.gov/parasites/causes/index.html, Accessed 2025.
  73. Martinsen TC, Fossmark R, Waldum HL. The Phylogeny and Biological Function of Gastric Juice-Microbiological Consequences of Removing Gastric Acid. International journal of molecular sciences.2019;20(23).
  74. Shelton AA. Sexually transmitted parasitic diseases. Clinics in colon and rectal surgery. 2004;17(4):231-234.
  75. Forson AO, Arthur I, Olu-Taiwo M, Glover KK, Pappoe-Ashong PJ, Ayeh-Kumi PF. Intestinal parasitic infections and risk factors: a cross-sectional survey of some school children in a suburb in Accra, Ghana. BMC research notes. 2017;10(1):485.
  76. CDC. About Pinworm Infection. 2024; https://www.cdc.gov/pinworm/about/index.html, Accessed 2025.

 

Related Articles